Nasdaq
$2.81▼ 2.43%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $114.2MShares out 40.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 5d agoAfter-hours26.10.20 05:058-KKey event#●●●#●●●
Scienture Holdings, Inc.Bullish
Scienture Holdings (SCNX) announced preliminary Q3 2026 revenue of approximately $1.22 million, representing a 256% increase from the previous quarter. Additionally, the company regained compliance with Nasdaq's minimum bid price requirement after maintaining a closing bid price of at least $1.00 for ten consecutive trading days, ensuring its continued listing.…more
$2.81-2.43%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.7After-hours26.10.08 06:298-KKey event
Scienture Holdings, Inc.
Scienture Holdings (SCNX) effected a 1-for-25 reverse stock split on October 5, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The total number of outstanding shares was reduced from 41,064,146 to approximately 1,642,565, with fractional shares settled in cash.…more
$2.81-2.43%vs prev closeView filingShare - 9.18After-hours26.09.19 05:05DEF 14AOther
Scienture Holdings, Inc.
Scienture Holdings will hold its 2026 annual meeting of stockholders on October 28, 2026, to elect five directors, ratify the appointment of CM3 Advisory as the independent auditor, and conduct an advisory vote on executive compensation. Shareholders may cast their votes online or via telephone to finalize the company's governance and audit structure.…more
$2.81-2.43%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.22 21:13#●●●#●●●#●●●
Scienture Holdings Reports 256% Q3 Revenue Growth, Targets 2027 Profitability…more
Scienture Holdings reported a 256% sequential revenue increase to $1.22 million in the third quarter, driven by the commercial success of its FDA-approved products. The company aims to leverage its existing infrastructure to achieve profitability by 2027.…more
$2.81-2.43%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 3d agoPre-market26.10.22 21:05
●●●●●●●● ●●●●● ●●●●●●
Scienture Holdings announced a 256% sequential revenue increase in the third quarter, driven by the growth of its two FDA-approved commercial products. The company aims to achieve profitability by 2027, leveraging high gross margins and established commercial infrastructure.…more
$2.81-2.43%vs prev close - 10.13Pre-market26.10.13 21:00
●●●●●●●● ●●●●● ●●●●●●
Scienture announced preliminary third-quarter sales of approximately $1.22 million, marking a 256% sequential increase. The growth was driven by a 74% sequential rise in sales from its Arbli wholesale unit.…more
$2.81-2.43%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report